TrialInvestigational new drugs2023

A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer.

Naminatsu Takahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.